An open label trial of C-1073 (mifepristone) for psychotic major depression

Biological Psychiatry

Volumn 52, Issue 5, 2002, Pages 386-392

  Belanoff, Joseph K ^a   Rothschild, Anthony J ^b   Cassidy, Frederick ^c   DeBattista, Charles ^d   Baulieu, Etienne Emile ^e   Schold, Clifford ^f   Schatzberg, Alan F ^d  

^a Corcept Therapeutics Inc ^*  (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e INSERM   (France)

^f DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

C 1073 Mifepristone; Cortisol; Psychotic major depression

Indexed keywords

C 1073; GLUCOCORTICOID ANTAGONIST; MIFEPRISTONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MUSCLE CRAMP; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RATING SCALE; TREATMENT OUTCOME;

ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HORMONE ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MIFEPRISTONE; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0036752158     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01432-4     Document Type: Article

References (72)

1. Ammar S., Allilaire J.-F., Lecrubier Y.M., Widlocher D., Baulieu E.E. Letter Afternoon increase in plasma cortisol in depressed patients receiving an antiglucocorticosteroid in the morning . Am J Psychiatry. 143:1986;129-130.
2. Anton R.F. Urinary free cortisol in psychotic depression. Biol Psychiatry. 22:1987;24-34.
3. Anton R.F., Burch E.A. Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression. Am J Psychiatry. 147:1990;1203-1208.
4. Arana G.W., Barreira P.J., Cohen B.M., Lipinski J.F., Fogelson D. The dexamethasone suppression test in psychotic disorders. Am J Psychiatry. 140:1983;1521-1523.
5. Avery D., Lubrano A. Depression treated with imipramine and ECT The DeCarolis study reconsidered . Am J Psychiatry. 136:1979;559-562.
6. Belanoff J., Flores B., Kalezhan M., Sund B., Schatzberg A. Rapid reversal of psychotic major depression using mifepristone. J Clin Psychopharmacol. 21:2001;516-521.
7. Belanoff J.K., Kalehzan M., Sund B., Fleming Fice K.S., Schatzberg A.F. Cortisol activity and cognitive changes in psychotic major depression. Am J Psychiatry. 158:2001;1612-1616.
8. Bertagna X., Escourolle H., Pinquier J.L., Coste J., Roux-DeMay M.C., Perles P., et al. Administration of RU486 for 8 Days in normal volunteers Antiglucocorticoid effect with no evidence of peripheral cortisol deprivation . J Clin Endocrinol Metab. 78:1994;375-380.
9. Chan C.H., Janicak P.G., Davis J.M., Altman E., Andriukaitis S., Hedeker D. Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry. 48:1987;197-200.
10. Charney D.S., Nelson J.C. Delusional and nondelusional unipolar depression Further evidence for distinct subtypes . Am J Psychiatry. 138:1981;328-333.
11. Chrousos GP, Laue L, Nieman LK, Udelsman R, Kawai S, Loriaux DL (1989): Clinical applications of RU 486, a prototype glucocorticoid and progestin antagonist. In: The Adrenal and Hypertension: From Cloning to Clinic 57 of Serono Symposia. New York: Raven Press, pp 273-284.
12. Chu J.W., Matthias D.F., Belanoff J., Schatzberg A., Hoffman A.R., Feldman D. Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486). J Clin Endocrinol Metab. 86:2001;3568-3573.
13. Coryell W., Pfohl B., Zimmerman M. The clinical and neuroendocrine features of psychotic depression. J Nerv Ment Dis. 172:1984;521-528.
14. Croxatto H.B., Salvatierra A.M., Croxatto H.D., Fuentealba B. Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum Reprod. 8:1993;201-207.
15. Frances A., Brown R.P., Kocsis J.H., Mann J.J. Psychotic depression A separate entity . Am J Psychiatry. 138:1981;831-833.
16. Gaillard R.C., Riondel A., Muller A.F., Herrmann W., Baulieu E.E. RU 486 A steriod with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day . Med Sci. 81:1984;3879-3882.
17. Gatti F., Bellini L., Gasperini M., Perez J., Zanardi R., Smeraldi E. Fluvoxamine alone in the treatment of delusional depression. Am J Psychiatry. 153:1996;414-416.
18. Glassman A.H., Kantor S.J., Shostak M. Depression, delusions, and drug response. Am J Psychiatry. 132:1975;716-719.
19. Glassman A.H., Roose S.P. Delusional depression A distinct clinical entity . Arch Gen Psychiatry. 38:1981;424-427.
20. Glassman A.H., Roose S.P. Delusional depression Tricyclic response . Arch Gen Psychiatry. 43:1986;1014.
21. Grunberg S.M., Weiss M.H., Spitz I.M., Zaretsky S., Kletzky O., Groshen S. Long-term treatment with the oral antiprogestational agent mifepristone (RU486). Salmon S.E., Adjuvant Therapy of Cancer VII. Vol. VII:1993;J. B. Lippincott, Philadelphia.
22. Halbreich U., Zumoff B., Kream J., Fukushima D.K. The mean 1300-1600 h plasma cortisol concentration as a diagnostic test for hypercortisolism. J Clin Endocrinol Metab. 54:1982;1262-1264.
23. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
24. Herrmann W., Riondel A., Philibert D. Effet d'un steroide anti-progesterone chez la femme Interuption du cycle menstrul et de la grossese au debut . Comtes Rendus. 294:1982;922-938.
25. Group CCS, Kane J.M., Honigfeld G., Singer J., Meltzer H.Y. Clozapine for the treatment-resistant schizophrenic A double-blind comparison with chlorpromazine . Arch Gen Psychiatry. 45:1988;789-796.
26. Kantor S.J., Glassman A.H. Delusional depressions Natural history and response to treatment . Brit J Psychiatry. 131:1977;351-360.
27. Kettel L.M., Murphy A.A., Morales A.J., Ulmann A., Baulieu E.E., Yen S.S.C. Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril. 65:1996;23-28.
28. Kettel L.M., Murphy A.A., Mortola J.F., Liu J.H., Ulmann A., Yen S.S.C. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis. Fertil Steril. 56:1991;402-407.
29. Kronig M.H., Munne M.R., Szymanski S., Safferman A.Z., Pollack S., Cooper T., et al. Plasma clozapine levels and clinical response for treatment refractory schizophrenic patients. Am J Psychiatry. 152:1995;179-192.
30. Lamberts SWJ, Bons EG, Uitterlinden P (1984): Studies on the glucocorticoid receptor blocking action of mifepristone in clultured ACTH-secreting human pituitary tumor cells and normal rat pituitary cells. J Steroid Biochem 17.
31. Lamberts S.W.J., Koper J.W., Jong F.H. The endocrine effects of long-term treatment with mifepristone (RU 486). J Clin Endocrinol Metab. 73:1991;187-191.
32. Laue L., Lotze M.T., Chrousos G.P., Barnes K., Loriaux D.L., Fleisher T.A. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man Toxicity, immunological, and hormonal aspects . J Clin Endocrinol and Metab. 71:1990;1474-1480.
33. Leckman J.F., Weissman M.M., Prusoff B.A., Carvso K.A., Meri Kangas K.A., Pauls D.L., Kidd K.K. Subtypes of depression family study perspective. Arch Gen Psychiatry. 41:1984;833-838.
34. Ledger W.L., Sweeting V.M., Hillier H., Baird D.T. Inhibition of ovulation by low-dose mifepristone (RU 486). Hum Reprod. 7:1992;945-950.
35. Luukkainen T., Heikinheimo O., Haukkamaa M., Lahteenmaki P. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. Fertil Steril. 49:1988;961-963.
36. Lykouras E., Malliaras D., Christodoulou G.N., Moussas G., Christodoulou D., Tzonou A. Delusional depression Phenomenology and response to treatment . Psychopathology. 19:1986;157-164.
37. Lyons D.M., Lopez J.M., Yang C., Schatzberg A.F. Stress-level cortisol treatment impairs inhibitory control of behavior in monkeys. J Neurosci. 20:2000;7816-7821.
38. Minter R.E., Mandel M.R. The treatment of psychotic major depressive disorder with drugs and electroconvulsive therapy. J Nerv Ment Dis. 167:1979;726-733.
39. Mitchell P., Smythe G., Torda T. Effect of the anesthetic agent propofol on hormonal responses to ECT. Biol Psychiatry. 28:1990;315-324.
40. Muck-Seler D., Pivac N., Jakovljevic M., Brzovic Z. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients. Biol Psychiatry. 45:1999;1433-1439.
41. Murphy A., Kettel L.M., Morales A.J., Roberts V., Parmley T., Yen S.S. Endometrial effects of long-term, low dose administration of RU 486. Fertil Steril. 63:1995;761-766.
42. Murphy A.A., Morales A.J., Kettel L.M., Yen S.S. Regression of uterine leiomyomata to the antiprogesterone RU486 Dose-response effect . Fert Steril. 64:1995;187-190.
43. Murphy B.E.P., Filipini D., Ghadirian A.M. Possible use of glucocorticoid receptor antagonists in the treatment of major depression Preliminary results using RU 486 . J Psychiatr Neurosci. 18:1993;209-213.
44. Nelson C., Bowers M.B. Jr. Delusional unipolar depression. Arch Gen Psychiatry. 35:1978;1321-1328.
45. Nelson J.C., Davis J.M. DST studies in psychotic depression A meta-analysis . Am J Psychiatry. 154:1997;1497-1503.
46. Nelson W.H., Khan A., Orr W.W. Jr. Delusional depression Phenomenology, neuroendocrine function, and tricyclic antidepressant response . J Affect Disord. 6:1984;297-306.
47. Newcomer J.W., Selke G., Melson A.K., Hershey T., Craft S., Richards K., Anderson A.L. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry. 56:1999;527-533.
48. Nieman L.K. Uses of mifepristone as a glucocorticoid antagonist. Benet L.Z., Dorflinger L., Dondaldson M.S., Brown S.S., Clinical Applications of Mifepristone (Ru 486 and other Antiprogestins. 1993;139-147 National Academy Press, Washington, DC.
49. Nieman L.K., Chrovsos G.P., Kellner C., Spitz I.M., Nisula B.C., Cutler G.B., et al. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab. (61):1993;536-540.
50. Nierenberg A.A., Farabaugh A.H., Alpert J.E., Gordon J., Worthington J.J., Rosenbaum J.F. Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry. 157:2000;1423-1427.
51. Nobler M., Sackeim H.A., Moeller J., Prudic J., Petkova E., Waternaux C. Quantifying the speed of symptomatic improvement with electroconvulsive therapy Comparison of alternative statistical methods . Convuls Ther. 13:1997;208-221.
52. Patel P.D., Lopez J.F., Lyons D.M., Burke S., Wallace M., Schatzberg A.F. Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res. 34:2000;383-392.
53. Proulx-Ferland Cote L, Philibert D, Deraedt R (1982): Potent antiglucocorticoid activity of RU38486 on ACTH secretion in vitro and in vivo in the rat. J Steroid Biochem 17:27.
54. Robinson D.G., Spiker D.G. Delusional depression A one year follow-up . J Affect Disord. 9:1985;79-83.
55. Rothschild A.J. Delusional depression A review of the literature and current perspectives . McLean Hosp J. 10:1985;68-83.
56. Rothschild A.J., Phillips K.A. Selective serotonin reuptake inhibitors and delusional depression. Am J Psychiatry. 156:1999;977-978.
57. Rothschild A.J., Schatzberg A., Rosenbaum A.H., Stahl J.B., Cole J.O. The dexamethasone suppression test as a discriminator among subtypes of psychotic patients. Am J Psychiatry. 141:1982;471-474.
58. Sanchez M.M., Young L.J., Plotsky P.M., Insel T.R. Distribution of corticosteroid receptors in the rhesus brain Relative absence of glucocortiocid receptors in the hippolcampal formation . J Neurosci. 20:2000;4657-4668.
59. Sartor O., Cutler G.B. Jr. Mifepristone Treatment of Cushing's syndrome . Clin Obstet Gynecol. 39:1996;506-510.
60. Schatzberg A., Posener J.A., DeBattista C., Kalehzan M., Rothschild A.J., Shear P.K. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness. Am J Psychiatry. 157:2000;1095-1100.
61. Schatzberg A., Rothschild A.J., Langlais P.J., Bird E.D., Cole J.O. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiatr Res. 19:1985;57-64.
62. Schatzberg A.F., Rothschild A.J. Psychotic (delusional) major depression Should it be included as a distinct syndrome in DSM-IV . Am J Psychiatry. 149:1992;733-745.
63. Shoupe D., Mishell D.R. Jr, Lahteenmaki P., Heikinheimo O., Birgerson L., Madkour H. Effects of the antiprogesterone RU 486 in normal women. 1 Single-dose administration in the midluteal phase . Am J Obstet Gynecol. 157:1987;1415-1420.
64. Spiker D.G., Weiss J.C., Dealy R.S., et al. The pharmacological treatment of delusional depression. Am J Psychiatry. 142:1985;430-436.
65. Swartz C., Chen J.-J. Electroconvulsive therapy-induced cortisol release Changes with depressive state . Convul Ther. 1:1985;15-21.
66. Tollefson G (2001): The use of olanzapine-fluoxetine combination in the treatment of major depressive disorder with psychotic features. NIMH Clinical Drug Evaluation Unit Meeting (NCDEU), Phoenix, AZ.
67. Van der Lely A.-J., Foeken K., van der Mast R.C., Lamberts S.W.J. Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Int Med. 114:1991;143-144.
68. Wolkowitz O.M., Reus V.I., Chan T., Manfredi F., Raum W., Johnson R. Antiglucocorticoid treatment of depression Double-blind ketoconazole . Biol Psychiatry. 45:1999;1070-1074.
69. Wolkowitz O.M., Reus V.I., Manfredi F., Ingbar J., Brizendine L., Weingartner H. Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry. 150:1993;810-812.
70. Zanardi R., Franchini L., Gasperini M., Perez J., Smeraldi E. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression. Am J Psychiatry. 153:1996;1631-1633.
71. Zanardi R., Franchini L., Gasperini M., Smeraldi E., Perez J. Long-term treatment of psychotic (delusional) depression with fluvoxamine: An open pilot study. Int Clin Psychopharmacol. 12:1997;195-197.
72. Zanardi R., Franchini L., Serretti A., Perez J., Smeraldi E. Venlafaxine versus fluvoxamine in the treatment of delusional depression A pilot double-blind controlled study . J Clin Psychiatry. 61:2000;26-29.